Is Exemestane Tablets a targeted drug?
Nov 28, 2024
Source: Cainiu Health
Dr. Qi Zhirong
Introduction
Under normal circumstances, Exemestane tablets do not belong to targeted drugs but are a type of endocrine medication with endocrine-regulating effects. They primarily work by inhibiting aromatase activity and reducing estrogen levels in the body. They are commonly used in postmenopausal patients with hormone receptor-positive early breast cancer, as well as in those with recurrent or metastatic breast cancer.
Under normal circumstances, Exemestane tablets do not belong to the category of targeted drugs, but rather are a type of endocrine therapy medication. Detailed analysis is as follows:
Targeted drugs achieve therapeutic effects by acting on specific molecular targets. Exemestane tablets belong to aromatase inhibitors and are primarily indicated for the treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for controlling recurrent or metastatic breast cancer in postmenopausal patients. It works by inhibiting aromatase activity and lowering estrogen levels in the body, thus achieving therapeutic goals. This mechanism falls under endocrine therapy rather than targeted therapy, and its therapeutic principle differs from that of targeted drugs.
Before using Exemestane tablets, patients should understand their own health conditions. Those allergic to the drug's components should not use it. Special populations such as premenopausal women, nursing mothers, and pregnant women are contraindicated for this medication. Regardless of the type of medication, it should always be taken under the guidance of a physician, and self-administration should be avoided.
